Selected developments and initiatives in 4Q18 from major sources of public funding including National Institutes of Health (NIH), the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes of Health Research (CIHR), the Agency for Science Technology and Research (A*STAR) and the Japan Agency for Medical Research and Development (AMED).
|Oct. 1||NIH||The INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down SyndromE) project awarded $22.2 million in grants as part of NIH's $59 million mandate for Down syndrome research in FY18.||Grants|
|Oct. 1||CIHR||Michael Strong began his tenure as CIHR president, replacing|